Back to ZNTL
CITADEL ADVISORS LLC ZNTL Position History
Zentalis Pharmaceuticals, Inc. • Healthcare
Quarters held
15
Latest value
$191K
Q3 2026
Peak value
$10.7M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $4.1M |
| Q1 2026 | $30K |
| Q1 2026 | $26K |
| Q2 2026 | $10.7M |
| Q2 2026 | $129K |
| Q2 2026 | $481K |
| Q2 2026 | $63K |
| Q2 2026 | $10.7M |
| Q2 2026 | $129K |
| Q2 2026 | $481K |
| Q2 2026 | $63K |
| Q3 2026 | $10M |
| Q3 2026 | $155K |
| Q3 2026 | $2.5M |
| Q3 2026 | $191K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $191K | 69.0K | — | — |
| Q3 2026 | $2.5M | 888.9K | — | — |
| Q3 2026 | $155K | 55.9K | — | — |
| Q3 2026 | $10M | 3.60M | — | — |
| Q2 2026 | $63K | 12.9K | — | — |
| Q2 2026 | $481K | 99.1K | — | — |
| Q2 2026 | $129K | 26.5K | — | — |
| Q2 2026 | $10.7M | 2.20M | — | — |
| Q2 2026 | $63K | 12.9K | — | — |
| Q2 2026 | $481K | 99.1K | — | — |
| Q2 2026 | $129K | 26.5K | — | — |
| Q2 2026 | $10.7M | 2.20M | — | — |
| Q1 2026 | $26K | 11.2K | — | — |
| Q1 2026 | $30K | 13.0K | — | — |
| Q1 2026 | $4.1M | 1.73M | — | — |